These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16336514)

  • 21. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications.
    Tan HL; Bardai A; Shimizu W; Moss AJ; Schulze-Bahr E; Noda T; Wilde AA
    Circulation; 2006 Nov; 114(20):2096-103. PubMed ID: 17088455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New perspectives in long QT syndrome].
    Medeiros-Domingo A; Iturralde-Torres P; Canizales-Quinteros S; Hernández-Cruz A; Tusié-Luna MT
    Rev Invest Clin; 2007; 59(1):57-72. PubMed ID: 17569301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex modulates the arrhythmogenic substrate in prepubertal rabbit hearts with Long QT 2.
    Liu T; Choi BR; Drici MD; Salama G
    J Cardiovasc Electrophysiol; 2005 May; 16(5):516-24. PubMed ID: 15877623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in autonomic modulation of ventricular repolarization in humans.
    Nakagawa M; Ooie T; Ou B; Ichinose M; Takahashi N; Hara M; Yonemochi H; Saikawa T
    J Cardiovasc Electrophysiol; 2005 Mar; 16(3):278-84. PubMed ID: 15817086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hands-on help Torsades de pointes.
    Dulak SB
    RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
    Hondeghem LM
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):337-40. PubMed ID: 16643415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low penetrance, subclinical congenital LQTS: concealed LQTS or silent LQTS?
    Varró A; Papp JG
    Cardiovasc Res; 2006 Jun; 70(3):404-6. PubMed ID: 16678140
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives.
    Kannankeril PJ; Roden DM; Norris KJ; Whalen SP; George AL; Murray KT
    Heart Rhythm; 2005 Feb; 2(2):134-40. PubMed ID: 15851285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced long QT syndrome in women.
    Li G; Cheng G; Wu J; Zhou X; Liu P; Sun C
    Adv Ther; 2013 Sep; 30(9):793-802. PubMed ID: 24085659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding drug-induced torsades de pointes: a genetic stance.
    Kannankeril PJ
    Expert Opin Drug Saf; 2008 May; 7(3):231-9. PubMed ID: 18462182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
    Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
    Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for men and women - how important is gender as a risk factor for TdP?
    Coker SJ
    Pharmacol Ther; 2008 Aug; 119(2):186-94. PubMed ID: 18472167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolong QT interval and "torsades de pointes" associated with different group of drugs.
    Gongadze N; Kezeli T; Antelava N
    Georgian Med News; 2007 Dec; (153):45-9. PubMed ID: 18250496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug induced QT prolongation: lessons from congenital and acquired long QT syndromes.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Yee R
    Curr Drug Targets Cardiovasc Haematol Disord; 2003 Dec; 3(4):327-35. PubMed ID: 14683474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians.
    Heist EK; Ruskin JN
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S1-8. PubMed ID: 16253926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.